Skip Navigation

Cardiovascular Research 1997 36(2):195-204; doi:10.1016/S0008-6363(97)00179-X
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ma, X. L
Right arrow Articles by Ischiropoulos, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, X. L
Right arrow Articles by Ischiropoulos, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Peroxynitrite aggravates myocardial reperfusion injury in the isolated perfused rat heart

Xin L Maa,*, Bernard L Lopeza, Gao-Lin Liua, Theodore A Christophera and Harry Ischiropoulosb

aDivision of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107-5004, USA
bInstitute for Environmental Medicine, University of Pennsylvania, Philadelphia, PA 19104-6068, USA

* Corresponding author. Tel. (+1-215) 9556844; Fax (+1-215) 9236225.

Objective: This study examined the effects of peroxynitrite (ONOO) on cardiac function and cellular injury following ischemia (30 min) and reperfusion (60 min) in isolated perfused rat hearts. Methods: 3-Morpholinosydnonimine (SIN-1, 0.1 mM), an ONOO donor, was administered alone or combined with superoxide dismutase (SOD, 300 U/ml) or glutathione (GSH, 1 mM) at the time of reperfusion. Results: Administration of SIN-1 alone significantly aggravated post-ischemic myocardial injury characterized by depressed cardiac function recovery (p<0.05 vs. vehicle), increased lactic dehydrogenase (LDH) and creatine kinase (CK) release (p<0.01 vs. vehicle), and enlarged necrotic size (p<0.01 vs. vehicle). The co-administration of either SOD to decrease the formation of ONOO, or GSH to increase the detoxification of ONOO, completely blocked the detrimental effects of SIN-1 and exerted significant cardioprotective effects against reperfusion injury. Conclusion: These results suggest that ONOO may play a significant role in postischemic myocardial injury.

KEYWORDS Peroxynitrite; Nitric oxide; Reperfusion injury


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Hataishi, A. C. Rodrigues, T. G. Neilan, J. G. Morgan, E. Buys, S. Shiva, R. Tambouret, D. S. Jassal, M. J. Raher, E. Furutani, et al.
Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H379 - H384.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Xu, I. A. Arenas, S. J. Armstrong, W. C. Plahta, H. Xu, and S. T. Davidge
Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-{alpha}
Cardiovasc Res, March 1, 2006; 69(4): 836 - 844.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schulz, M. Kelm, and G. Heusch
Nitric oxide in myocardial ischemia/reperfusion injury
Cardiovasc Res, February 15, 2004; 61(3): 402 - 413.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Brunner and G. Wolkart
Peroxynitrite-induced cardiac depression: role of myofilament desensitization and cGMP pathway
Cardiovasc Res, November 1, 2003; 60(2): 355 - 364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Laude, C. Thuillez, and V. Richard
Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1418 - H1423.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Gao, C.-L. Yao, E. Gao, Q.-Z. Mo, W.-L. Yan, R. McLaughlin, B. L. Lopez, T. A. Christopher, and X. L. Ma
Enhancement of Glutathione Cardioprotection by Ascorbic Acid in Myocardial Reperfusion Injury
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 543 - 550.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. Wang, G. Sawicki, and R. Schulz
Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2
Cardiovasc Res, January 1, 2002; 53(1): 165 - 174.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Padilla, D. Garcia-Dorado, L. Agullo, J. A Barrabes, J. Inserte, N. Escalona, M. Meyer, M. Mirabet, P. Pina, and J. Soler-Soler
Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs
Cardiovasc Res, August 15, 2001; 51(3): 592 - 600.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Zhang, J. W. Bissing, L. Xu, A. J. Ryan, S. M. Martin, F. J. Miller Jr, K. C. Kregel, G. R. Buettner, and R. E. Kerber
Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model
J. Am. Coll. Cardiol., August 1, 2001; 38(2): 546 - 554.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Jones, S. D. Trocha, and D. J. Lefer
Cardioprotective actions of endogenous IL-10 are independent of iNOS
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H48 - H52.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. S. Dhalla, A. B. Elmoselhi, T. Hata, and N. Makino
Status of myocardial antioxidants in ischemia-reperfusion injury
Cardiovasc Res, August 18, 2000; 47(3): 446 - 456.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Vinten-Johansen
Physiological Effects of Peroxynitrite : Potential Products of the Environment
Circ. Res., August 4, 2000; 87(3): 170 - 172.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Gao, T. A. Christopher, B. L. Lopez, E. Friedman, G. Cai, and X. L. Ma
Mechanism of decreased adenosine protection in reperfusion injury of aging rats
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H329 - H338.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T.-L. Yue, C. Wang, J.-L. Gu, X.-L. Ma, S. Kumar, J. C. Lee, G. Z. Feuerstein, H. Thomas, B. Maleeff, and E. H. Ohlstein
Inhibition of Extracellular Signal-Regulated Kinase Enhances Ischemia/Reoxygenation-Induced Apoptosis in Cultured Cardiac Myocytes and Exaggerates Reperfusion Injury in Isolated Perfused Heart
Circ. Res., March 31, 2000; 86(6): 692 - 699.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-L. Ma, F. Gao, B. L. Lopez, T. A. Christopher, and J. Vinten-Johansen
Peroxynitrite, a Two-Edged Sword in Post-Ischemic Myocardial Injury---Dichotomy of Action in Crystalloid- Versus Blood-Perfused Hearts
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 912 - 920.
[Abstract] [Full Text]


Home page
CirculationHome page
R. S. Ronson, V. H. Thourani, X.-L. Ma, S. L. Katzmark, D. Han, Z.-Q. Zhao, M. Nakamura, R. A. Guyton, and J. Vinten-Johansen
Peroxynitrite, the Breakdown Product of Nitric Oxide, Is Beneficial in Blood Cardioplegia but Injurious in Crystalloid Cardioplegia
Circulation, November 9, 1999; 100 (2009): II-384 - II-391.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. S Ronson, M. Nakamura, and J. Vinten-Johansen
The cardiovascular effects and implications of peroxynitrite
Cardiovasc Res, October 1, 1999; 44(1): 47 - 59.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart
Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury
Cardiovasc Res, August 15, 1999; 43(3): 698 - 711.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X. L. Ma, S. Kumar, F. Gao, C. S. Louden, B. L. Lopez, T. A. Christopher, C. Wang, J. C. Lee, G. Z. Feuerstein, and T.-L. Yue
Inhibition of p38 Mitogen-Activated Protein Kinase Decreases Cardiomyocyte Apoptosis and Improves Cardiac Function After Myocardial Ischemia and Reperfusion
Circulation, April 6, 1999; 99(13): 1685 - 1691.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.